Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.

The ability of NK cells to kill tumor cells is controlled by a balance between activating and inhibitory signals transduced by distinct receptors. In murine tumor models, the costimulatory molecule B7.1 not only acts as a positive trigger for NK-mediated cytotoxicity but can also overcome negative s...

Descrizione completa

Dettagli Bibliografici
Autori principali: Galea-Lauri, J, Darling, D, Gan, S, Krivochtchapov, L, Kuiper, M, Gäken, J, Souberbielle, B, Farzaneh, F
Natura: Journal article
Lingua:English
Pubblicazione: 1999
_version_ 1826261971426607104
author Galea-Lauri, J
Darling, D
Gan, S
Krivochtchapov, L
Kuiper, M
Gäken, J
Souberbielle, B
Farzaneh, F
author_facet Galea-Lauri, J
Darling, D
Gan, S
Krivochtchapov, L
Kuiper, M
Gäken, J
Souberbielle, B
Farzaneh, F
author_sort Galea-Lauri, J
collection OXFORD
description The ability of NK cells to kill tumor cells is controlled by a balance between activating and inhibitory signals transduced by distinct receptors. In murine tumor models, the costimulatory molecule B7.1 not only acts as a positive trigger for NK-mediated cytotoxicity but can also overcome negative signaling transduced by MHC class I molecules. In this study, we have evaluated the potential of human B7.1-CD28 interaction as an activating trigger for human blood NK cells. Using multiparameter flow cytometric analysis and a panel of different CD28 mAbs, we show that human peripheral blood NK cells (defined by CD56+, CD16+, and CD3- surface expression) express the CD28 costimulatory receptor, with its detection totally dependent on the mAb used. In addition, the level of CD28 varies among individuals and on different NK cell lines, irrespective of CD28 steady-state mRNA levels. By performing Ab binding studies on T cells, our data strongly suggest that binding of two of the anti-CD28 Abs (clones 9.3 and CD28.2) is to a different epitope to that recognized by clones L293 and YTH913.12, which is perhaps modified in the CD28 molecule expressed by the NK cells. We also show that B7.1 enhances the NK-mediated lysis of NK-sensitive but not of NK-resistant tumor cells and that this increased lysis is dependent on CD28-B7 interactions as shown by the ability of Abs to block this lysis. Coculture of the B7.1-positive NK-sensitive cells also led to the activation of the NK cells, as determined by the expression of CD69, CD25, and HLA class II.
first_indexed 2024-03-06T19:28:58Z
format Journal article
id oxford-uuid:1cc97b1f-a91f-43a9-b0bf-7ff1336d0885
institution University of Oxford
language English
last_indexed 2024-03-06T19:28:58Z
publishDate 1999
record_format dspace
spelling oxford-uuid:1cc97b1f-a91f-43a9-b0bf-7ff1336d08852022-03-26T11:07:28ZExpression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1cc97b1f-a91f-43a9-b0bf-7ff1336d0885EnglishSymplectic Elements at Oxford1999Galea-Lauri, JDarling, DGan, SKrivochtchapov, LKuiper, MGäken, JSouberbielle, BFarzaneh, FThe ability of NK cells to kill tumor cells is controlled by a balance between activating and inhibitory signals transduced by distinct receptors. In murine tumor models, the costimulatory molecule B7.1 not only acts as a positive trigger for NK-mediated cytotoxicity but can also overcome negative signaling transduced by MHC class I molecules. In this study, we have evaluated the potential of human B7.1-CD28 interaction as an activating trigger for human blood NK cells. Using multiparameter flow cytometric analysis and a panel of different CD28 mAbs, we show that human peripheral blood NK cells (defined by CD56+, CD16+, and CD3- surface expression) express the CD28 costimulatory receptor, with its detection totally dependent on the mAb used. In addition, the level of CD28 varies among individuals and on different NK cell lines, irrespective of CD28 steady-state mRNA levels. By performing Ab binding studies on T cells, our data strongly suggest that binding of two of the anti-CD28 Abs (clones 9.3 and CD28.2) is to a different epitope to that recognized by clones L293 and YTH913.12, which is perhaps modified in the CD28 molecule expressed by the NK cells. We also show that B7.1 enhances the NK-mediated lysis of NK-sensitive but not of NK-resistant tumor cells and that this increased lysis is dependent on CD28-B7 interactions as shown by the ability of Abs to block this lysis. Coculture of the B7.1-positive NK-sensitive cells also led to the activation of the NK cells, as determined by the expression of CD69, CD25, and HLA class II.
spellingShingle Galea-Lauri, J
Darling, D
Gan, S
Krivochtchapov, L
Kuiper, M
Gäken, J
Souberbielle, B
Farzaneh, F
Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
title Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
title_full Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
title_fullStr Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
title_full_unstemmed Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
title_short Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
title_sort expression of a variant of cd28 on a subpopulation of human nk cells implications for b7 mediated stimulation of nk cells
work_keys_str_mv AT galealaurij expressionofavariantofcd28onasubpopulationofhumannkcellsimplicationsforb7mediatedstimulationofnkcells
AT darlingd expressionofavariantofcd28onasubpopulationofhumannkcellsimplicationsforb7mediatedstimulationofnkcells
AT gans expressionofavariantofcd28onasubpopulationofhumannkcellsimplicationsforb7mediatedstimulationofnkcells
AT krivochtchapovl expressionofavariantofcd28onasubpopulationofhumannkcellsimplicationsforb7mediatedstimulationofnkcells
AT kuiperm expressionofavariantofcd28onasubpopulationofhumannkcellsimplicationsforb7mediatedstimulationofnkcells
AT gakenj expressionofavariantofcd28onasubpopulationofhumannkcellsimplicationsforb7mediatedstimulationofnkcells
AT souberbielleb expressionofavariantofcd28onasubpopulationofhumannkcellsimplicationsforb7mediatedstimulationofnkcells
AT farzanehf expressionofavariantofcd28onasubpopulationofhumannkcellsimplicationsforb7mediatedstimulationofnkcells